Gemtuzumab ozogamicin (Mylotarg) as a single agent for molecularly relapsed acute promyelocytic leukemia.
Lo-Coco F, Cimino G, Breccia M, Noguera NI, Diverio D, Finolezzi E, Pogliani EM, Di Bona E, Micalizzi C, Kropp M, Venditti A, Tafuri A, Mandelli F.
Lo-Coco F, et al. Among authors: breccia m.
Blood. 2004 Oct 1;104(7):1995-9. doi: 10.1182/blood-2004-04-1550. Epub 2004 Jun 8.
Blood. 2004.
PMID: 15187030
Free article.
Clinical Trial.